Admedus is a medical technologies company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


Clinically superior solutions that last a lifetime


Admedus AGM (July-December 2017) investor presentation
A copy of the Admedus Annual General Meeting presentation for the period July-December 2017 can be downloaded here. (Please note file
Read more.
TAVR progress continues with filing of new provisional patents
Admedus Limited (ASX:AHZ) today announced it has filed three new provisional patent applications in the United States as part of
Read more.